Professional Documents
Culture Documents
- LA/LA-opioid mixtures:
o Continuous lumbar epidural analgesia most versatile and commonly
employed technique analgesia for first as well as for subsequent vaginal
delivery/CS if necessary.
Walking epidural:
Very dilute LA mixtures in epidural (0.625%) generally do not produce motor blockade and
may allow some patients to ambulate.
Drug given: after 5 min when signs of IV and intrathecal injection is absent total 10 ml of
0.0625%-0.125% of Bupivacaine or 0.1-0.2% of Ropivacaine combined with 50-100 mcg
Fentanyl (in 5 ml increments waiting 1-2 min between doses). OR alternatively, continuous
epidural infusion using 0.0625-0.1% Bupi and 1-5 mcg/ml Fentanyl at 10 mL/h
OR, a patient controlled epidural analgesia (PCEA).
F/b monitoring with frequent BP for 20-30 min or until the patient is stable.
Deaths due to GA are related to airway problems (inability to intubate, inability to ventilate,
or aspiration pneumonia).
Treatment:
- Immediate steep Trendelenburg or keen chest position
- Manual pushing of the presenting fetal part back up into the pelvis until immediate
CS under GA can be performed.
- If the fetus is not viable, vaginal delivery is allowed to continue.
Arrest of dilation: when the cervix undergoes no further change after 2 h in the active phase
of labor.
Protracted active phase: slower than normal cervical dilation defined as less than 1.2 cm/h
in a nulliparous and less than 1.5 cm/h in multiparous.
Prolonged deceleration phase: when cervical dilation slows markedly after 8 cm. The cervix
becomes very edematous and appears to lose effacement.
Prolonged 2nd phase (disorder of descent): as a descent of less than 1 cm/h and 2 cm/h in
nulliparous and multiparous respectively.
Arrest of descent: Failure of the head to descend 1 cm in station after adequate pushing.
Drug of choice:
Oxytocin is DOC in the treatment of uterine contractile abnormalities.
Administration: IV at 1-6 mU/min and increased in increments of 1-6 mU/min every 15-40
min depending on the protocol.
Use of amniotomy is controversial.
Management is expectant: as long as the fetus and mother are tolerating the prolonged
labor.
When trial of oxytocin is unsuccessful or when malpresentation or CPD is also present,
operative vaginal or CS delivery is indicated.
Breech presentation
- Occur in 3-4% of deliveries.
- Increase neonatal mortality and incidence of cord prolapse >10X.
Management:
- ECV may be attempted after 34 weeks of gestation and prior to the onset of labor
(obstetrician may administer tocolytic agent at the same time)
o Role: ECV can be facilitated and its success rate improved by providing
epidural analgesia with 2% lidocaine and fentanyl.
o When unsuccessful: it can also cause placental abruption and umbilical cord
compression necessitating immediate CS.
o Role of epidural in Breech:
Need for breech extraction doesnt appear to be increased when
epidural is used for labor if labor is established prior to activation of
epidural.
Epidural anesthesia may decrease the likelihood of trapped head
because of relaxation of the perineum.
o If at all, head gets trapped even during regional, urgent RSI and GA to relax
uterus OR alternatively, Nitroglycerin 50-100 mcg IV may be administered.
Obstetric Hge:
1. Placenta Previa:
- Occurs if the placenta implants in advance of the fetal presenting part.
- 0.5% of pregnancies.
- Increase risk in females with:
o Previous CS or uterine myomectomy
o Multiparity
o Advanced maternal age
o Larger placenta
- Anterior lying placenta previa increases the risk of excessive bleeding for CS.
C/F:
o usually presents as painless vaginal bleeding.
o Often severe hge can occur at any time.
Management:
- When gestation <37 weeks and bleeding is mild to moderate: treated with bed rest
and observation.
- When >37 weeks: delivery by CS.
- Patient with low-lying placenta may rarely be allowed to deliver vaginally if bleeding
is mild.
- Active bleeding or unstable patients: require immediate CS under GA.
Preparation:
- Two large-bore IV catheters inplace
- Replacement of IV volume deficits.
- Blood must be available for transfusion.
2. Abruptio Placenta:
- Premature separation of normal placenta complicates approximately 1-2% of
pregnancies.
- Mild (grade I), moderate (II), severe (grade III)- 25%.
- Risk factors:
o HTN
o Trauma
o Short umbilical cord
o Multiparity
o Prolonged premature rupture of membrane
o Alcohol abuse
o Cocaine use
o Abnormal uterus
C/F:
- Painful vaginal bleeding
- Uterine contraction and tenderness
- An abdominal USG can help in the diagnosis
Choice of anesthetics:
- Based on urgency for delivery, maternal hemodynamic stability and any
coagulopathy (severe abruption may cause coagulopathy particularly after fetal
demise- fibrinogen levels <150 mg/dL d/t activation of circulating plasminogen
(fibrinogen) and the release of tissue thromboplastins that precipitate DIC; platelet
counts low and factors V and VIII are low, Fibrin split products increased.).
- Bleeding may remain concealed inside the uterus and cause underestimation of
blood loss.
Management:
- Life threatening condition
- Emergency CS
- Massive blood transfusion
- Replacement of coagulation factors and platelets.
3. Uterine rupture
- Relatively uncommon.
- Occurs d/t:
o Dehiscence of scar from previous CS, extensive myomectomy or uterine
reconstruction.
o Intrauterine manipulations or use of forceps (iatrogenic)
o Spontaneous rupture following prolonged labor in patients with hypertonic
contractions (oxytocin use), fetopelvic disproportion, or very large thin and
weakened uterus.
C/F:
- Frank Hge
- Fetal distress
- Loss of uterine tone
- Hypotension
- Occult bleeding into the abdomen
- Abrupt onset of continuous abdominal pain and hypotension.
T/t:
- Volume resuscitation
- Immediate laparotomy typically under GA
- Ligation of internal iliac arteries (hypogastric) with or without hysterectomy.
Chorioamnionitis:
- Principal maternal complications are:
o Premature or dysfunctional labor
o Intra-abdominal infection
o Septicemia
o PPH
- Fetal complications:
o Acidosis
o Hypoxia
o Septicemia
C/F:
- Fever (>38 deg C)
- Maternal and fetal tachycardia
- Uterine tenderness
- Foul smelling or purulent amniotic fluid
Lab: TLC (only if markedly elevated >15000/micL), CRP (>2 mg/dl), Gram staining of amniotic
fluid
Considerations:
- Use of regional anesthesia in chorioamnionitis is controversial (chance of
development of meningitis or epidural abscess)
- Concerns over hemodynamic stability: particularly in patients with chills, high fever,
tachypnea and changes and mental status or borderline hypotension.
- May have covert signs of septicemia, thrombocytopenia, or coagulopathy.
(Role: know that above mentioned drugs are given, eg. Magnesium
given (interaction with NMBD, vasodilation), its role, beta
adrenergic agonists are given thus their interaction, fetal is
premature thus need to resuscitate may be- eg. Ketamine/ephedrine
should be used cautiously).
Hypertensive Disorders:
HTN during pregnancy can be classified as:
o Pregnancy induced HTN: also referred to as preeclampsia
o Chronic HTN: that preceded pregnancy
o Chronic HTN with superimposed preeclampsia
- Preeclampsia:
o Is defined as SBP >140 mm Hg or DBP >90 mm Hg after the 20 th WOG
accompanied by proteinuria (>300 mg/d) and resolving within 48 h after
delivery.
o Complicates about 7-10% pregnancies.
o Severe preeclampsia causes 20-40% of maternal deaths and 20% of perinatal
deaths.
o Maternal deaths are usually d/t stroke, pulmonary edema, hepatic necrosis
or rupture.
o Severe features: BP >160/110 mm Hg, Proteinuria >5g/d, Oligura <500
ml/day, elevated serum creatinine, IUGR, pulmonary edema, CNS
manifestations (headache, visual disturbances, seizures, stroke), hepatic
tenderness, or HELLP syndrome.
- Eclampsia:
o Preeclampsia + Seizure
- Pathophysiology and Manifestations:
o Vascular dysfunction of the placenta resulting in abnormal metabolism of
prostaglandin.
o In preeclampsia: Elevated TXA2 and decreased PGI2
TXA2 is a potent vasoconstrictor and promoter of platelet
aggregation, PGI2 is a potent vasodilator and inhibitor of platelet
aggregation.
o Endothelial dysfunction may reduce production of NO and increase
production off ET-1 (a potent vasoconstrictor and platelet aggregator)
o Marked vascular reactivity and endothelial injury reduce placental perfusion
and lead to widespread systemic manifestations.
- T/T:
o Bed rest
o Sedation
o Repeated administration of antihypertensives
Labetalol: 5-10 mg IV
Hydralazine: 5 mg IV
Magnesium sulphate